Melinta Therapeutics, Inc. announced that it has received $15 million in funding from Eurofarma Laboratórios S.A.
Melinta Therapeutics, Inc. announced that it has received $15 million in an equity round of funding from new investor, Eurofarma Laboratórios S.A. on January 8, 2015. The investor acquired 3% stake of the company through this transaction.
On January 8, 2015, Melinta Therapeutics, Inc. closed the transaction.